Barclays’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-7,300
| Closed | -$319K | – | 6180 |
|
|
2020
Q1 | $319K | Buy |
7,300
+3,700
| +103% | +$177K | ﹤0.01% | 3945 |
|
|
2019
Q4 | $181K | Sell |
3,600
-2,000
| -36% | -$93.7K | ﹤0.01% | 5111 |
|
|
2019
Q3 | $259K | Sell |
5,600
-14,500
| -72% | -$625K | ﹤0.01% | 4772 |
|
|
2019
Q2 | $870K | Sell |
20,100
-81,100
| -80% | -$3.45M | ﹤0.01% | 3830 |
|
|
2019
Q1 | $4.48M | Buy |
101,200
+96,900
| +2,253% | +$4.15M | ﹤0.01% | 1743 |
|
|
2018
Q4 | $187K | Sell |
4,300
-9,100
| -68% | -$401K | ﹤0.01% | 4622 |
|
|
2018
Q3 | $599K | Buy |
13,400
+9,000
| +205% | +$384K | ﹤0.01% | 4113 |
|
|
2018
Q2 | $176K | Sell |
4,400
-89,000
| -95% | -$3.5M | ﹤0.01% | 4830 |
|
|
2018
Q1 | $3.74M | Buy |
93,400
+63,100
| +208% | +$2.63M | ﹤0.01% | 1855 |
|
|
2017
Q4 | $1.3M | Sell |
30,300
-13,500
| -31% | -$622K | ﹤0.01% | 2835 |
|
|
2017
Q3 | $2.18M | Buy |
43,800
+8,100
| +23% | +$392K | ﹤0.01% | 2255 |
|
|
2017
Q2 | $1.71M | Buy |
35,700
+17,000
| +91% | +$812K | ﹤0.01% | 2389 |
|
|
2017
Q1 | $846K | Sell |
18,700
-300
| -2% | -$12.7K | ﹤0.01% | 2880 |
|
|
2016
Q4 | $768K | Buy |
19,000
+13,500
| +245% | +$532K | ﹤0.01% | 2987 |
|
|
2016
Q3 | $210K | Buy |
5,500
+1,700
| +45% | +$68.2K | ﹤0.01% | 3933 |
|
|
2016
Q2 | $159K | Sell |
3,800
-68,600
| -95% | -$2.81M | ﹤0.01% | 4093 |
|
|
2016
Q1 | $2.9M | Buy |
72,400
+53,900
| +291% | +$2.17M | ﹤0.01% | 1618 |
|
|
2015
Q4 | $777K | Buy |
18,500
+4,600
| +33% | +$212K | ﹤0.01% | 2829 |
|
|
2015
Q3 | $653K | Sell |
13,900
-15,200
| -52% | -$774K | ﹤0.01% | 3115 |
|
|
2015
Q2 | $1.43M | Buy |
29,100
+15,500
| +114% | +$786K | ﹤0.01% | 2548 |
|
|
2015
Q1 | $666K | Sell |
13,600
-19,700
| -59% | -$942K | ﹤0.01% | 3321 |
|
|
2014
Q4 | $1.5M | Buy |
33,300
+14,500
| +77% | +$704K | ﹤0.01% | 2795 |
|
|
2014
Q3 | $1.05M | Buy |
18,800
+12,400
| +194% | +$666K | ﹤0.01% | 3301 |
|
|
2014
Q2 | $339K | Sell |
6,400
-3,100
| -33% | -$165K | ﹤0.01% | 4340 |
|
|
2014
Q1 | $494K | Sell |
9,500
-18,400
| -66% | -$931K | ﹤0.01% | 3972 |
|
|
2013
Q4 | $1.48M | Buy |
27,900
+3,400
| +14% | +$175K | ﹤0.01% | 2967 |
|
|
2013
Q3 | $1.23M | Sell |
24,500
-6,500
| -21% | -$331K | ﹤0.01% | 3124 |
|
|
2013
Q2 | $1.6M | Buy |
+31,000
| New | +$1.65M | ﹤0.01% | 2793 |
|
Other funds holding SNY
MIP
Barclays's SNY Position: Q1 2026 in Review
Barclays increased its Sanofi (SNY) stake by 10% in Q1 2026, buying an estimated $10.4M and bringing the position to 2,356,559 shares worth $114M. The position accounts for 0.03% of the portfolio, ranked #451.
Barclays first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Barclays held 2,356,559 shares of Sanofi worth $114M as of Q1 2026.
- Barclays bought 222,503 Sanofi shares in Q1 2026, an estimated $10.4M.
- Sanofi made up 0.03% of Barclays's portfolio in Q1 2026, its #451 holding.
- Barclays first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
- 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.